Cargando…

Plasmodium vivax malaria vaccines: Why are we where we are?

Malaria is one of the few diseases in which morbidity is still measured in hundreds of millions of cases every year. Plasmodium vivax and Plasmodium falciparum are responsible for nearly all the malaria cases in the world and despite difficulties in obtaining an exact number, estimates indicate an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reyes-Sandoval, Arturo, Bachmann, Martin F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162059/ https://www.ncbi.nlm.nih.gov/pubmed/23978931 http://dx.doi.org/10.4161/hv.26157

Ejemplares similares

Plasmodium vivax pre-erythrocytic vaccines
por: Reyes-Sandoval, Arturo
Publicado: (2021)

Development of a Plasmodium vivax malaria vaccine for clinical applications using transgenic parasites, virus-like particles and recombinant viruses
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2014)

Extradural hematoma in Plasmodium vivax malaria: Are we alert to detect?
por: SenthilKumaran, S., et al.
Publicado: (2013)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)

Implementation of Outpatient Total Joint Arthroplasty in Canada: Where We are and Where We Need to Go
por: Zomar, Bryn O, et al.
Publicado: (2020)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
por: Alves, Eduardo, et al.
Publicado: (2017)

Ventilator-associated tracheobronchitis: where are we now?
por: Nseir, Saad, et al.
Publicado: (2014)

Dermatology education in skin of colour: where we are and where do we go?
por: Onasanya, Joshua, et al.
Publicado: (2021)

Where we are with point-of-care testing
por: Johannessen, A
Publicado: (2015)

Electronic cigarettes – where are we headed?
por: Loughead, Andrew
Publicado: (2015)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

TB vaccine development: where are we and why is it so difficult?
por: Wilkie, Morven E M, et al.
Publicado: (2015)

Predicting Molecular Models: Where Are We Going?
por: Ratta, Raffaele, et al.
Publicado: (2015)

Genetics and primary care: where are we headed?
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2014)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

Development of novel vaccine candidates and challenge models for Plasmodium vivax
por: Alves, Eduardo, et al.
Publicado: (2014)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

We need to talk more about transfusion-transmitted malaria in Plasmodium vivax endemic areas()
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2014)

Introduction of a rapid response system: why we are glad we MET
por: Jones, Daryl, et al.
Publicado: (2006)

Hepatitis C Vaccination: Where We Are and Where We Need to Be
por: Manne, Vignan, et al.
Publicado: (2021)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

Food safety in Vietnam: where we are at and what we can learn from international experiences
por: Nguyen-Viet, Hung, et al.
Publicado: (2017)

Dental genetics in Brazil: Where we are
por: Casado, Priscila L., et al.
Publicado: (2018)

Women in neuroscience: Where are we in 2019?
por: Machlovi, Saima, et al.
Publicado: (2020)

Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

The WHO pandemic treaty: where are we on our scepticism?
por: Evaborhene, Nelson Aghogho, et al.
Publicado: (2023)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Prevention and control of malaria and sleeping sickness in Africa: Where are we and where are we going?
por: Corbel, Vincent, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sjl29lhp8aega2aevaed32s1i7